Project Grant S10OD036268

Award Date 8/15/24
Completion Date 8/14/25
Dollars Obligated $1.5M
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
New York, NY 10031, USA
Similar Awards
The National Institute of General Medical Sciences (NIGMS) awarded a $1,481,998 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the University of Illinois Chicago (UIC), a minority-serving institution, to acquire a dual-source ion mobility mass spectrometry system. This state-of-the-art instrumentation will enable advanced proteomics, lipidomics, and metabolomics research by a diverse group of biomedical researchers at UIC and their collaborators. The...
The National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training Program (CFDA 93.859), awarded Colorado State University a $506,020 Project Grant to purchase a new 400 MHz nuclear magnetic resonance (NMR) spectrometer. This instrument will be used to expand the analytical capacity of the university's Analytical Resources Core (ARC) facility, allowing increased 1D and 2D NMR data collection to support the research of undergraduate and graduate...
The New York Structural Biology Center, Inc. has been awarded a $1,995,724 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) to acquire a state-of-the-art 800 MHz NMR spectrometer console and associated probes. This instrumentation will enhance the capacity of the existing 800 MHz NMR system to support a range of NIH-funded structural biology research, from fundamental studies of biomolecular...
The National Institute of General Medical Sciences (NIGMS) awarded a $249,986 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the Research Foundation of the City University of New York (RFCUNY) to acquire a microwave-assisted peptide synthesizer. This instrument will enable RFCUNY to efficiently synthesize peptidomimetics, peptide-based biosensors, and small enzymes in a cost-effective and eco-friendly manner. The key objectives are to develop novel...
The National Institute of General Medical Sciences (NIGMS) awarded a $719,476 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the University of California, Irvine (UC Irvine) to acquire a state-of-the-art MALDI-QTOF mass spectrometer for imaging mass spectrometry (MALDI IMS). This instrument will support multiple NIH-funded research projects at UC Irvine, including studies on neuropathological proteins and lipids in Alzheimer's disease models, metabolic...
The Project Grant award R35GM153179, totaling $939,086 and funded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), supports the development of novel mass spectrometry-based technologies for profiling biomolecular expression at the single-cell level. The key products and services to be delivered under this five-year project include: Developing global and targeted approaches to profile post-translational...
This $3,999,999 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) will fund the acquisition of a Glacios 2 cryo-electron microscope (cryo-EM) at the Icahn School of Medicine at Mount Sinai (ISMMS). The goal is to enable researchers throughout the institution to conduct high-resolution structural analysis of diverse biological systems and disease mechanisms using single-particle cryo-EM. This new...
This $1,574,994 Project Grant award from the National Institutes of Health (NIH) under the Research Infrastructure Programs (CFDA 93.351) will support the acquisition of a state-of-the-art high-resolution tandem mass spectrometer at the University of California, Los Angeles (UCLA). The instrument will enable advanced structural characterization of a broad range of large biological and synthetic molecules, supporting over 11 NIH-funded research projects at UCLA. The mass spectrometer will provide...
This $1 Project Grant award from the National Institutes of Health's (NIH) Research Infrastructure Programs (CFDA 93.351) will enable the acquisition of a Thermo Scientific Orbitrap IQ-X Tribrid mass spectrometer coupled to a Vanquish dual column liquid chromatography system. The instrument will be housed at the University of Pennsylvania's Translational Biomarker Core, serving over 80 investigators for lipidomics, metabolomics, isotope tracing, and structural elucidation experiments. This...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports the development of a novel liquid chromatography-mass spectrometry (LC-MS) platform for rapid, real-time online monitoring of targeted small molecule metabolites in complex biological systems. The $375,000 award to Rowan University will fund research to create a sensor-like LC-MS system capable of high-throughput gradient separations,...

The National Institute of General Medical Sciences (NIGMS) awarded a $1,469,739 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the Research Foundation of the City University of New York (RFCUNY) - Advanced Science Research Center. The grant, awarded on August 15, 2024, will be used to purchase a TIMSTOF-FLEX MALDI-2 high-resolution mass spectrometer with trapped-ion mobility and dual ion-source capabilities. This instrumentation will support biomedical research projects across twelve laboratories at CUNY and nearby institutions, focusing on conformational dynamics of light-sensitive proteins and macromolecular assemblies, as well as metabolic signals regulating tumor progression, axonal regeneration, and neurodegenerative processes. The advanced mass spectrometry capabilities will enable separation of challenging isomeric and isobaric species, enhance sensitivity and resolution of molecular measurements, and provide integrated MALDI-imaging and omics analysis. The instrument will be housed and managed within the ASRC Mass Spectrometry Core Shared Facility to advance collaborative research efforts in structural biology, neuroscience, and other biomedical disciplines.

Generated 6/10/25, 3:27 AM